{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:12:58Z","timestamp":1789809178200,"version":"4.0.1"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T00:00:00Z","timestamp":1421884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00401-015-1391-6","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T03:39:40Z","timestamp":1421811580000},"page":"467-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc"],"prefix":"10.1007","volume":"129","author":[{"given":"Lidia","family":"Stork","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bar-Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,22]]},"reference":[{"key":"1391_CR1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJMc1304828","volume":"370","author":"Giacomini PS, Rozenberg A, Metz I, Araujo D, Arbour N, Bar-Or A; Maraviroc in Multiple Sclerosis-Associated PML\u2013IRIS (MIMSAPI) Group","year":"2014","unstructured":"Giacomini PS, Rozenberg A, Metz I, Araujo D, Arbour N, Bar-Or A; Maraviroc in Multiple Sclerosis-Associated PML\u2013IRIS (MIMSAPI) Group (2014) Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome. N Engl J Med 370:486\u2013488. doi: 10.1056\/NEJMc1304828","journal-title":"N Engl J Med"},{"key":"1391_CR2","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1097\/QAD.0b013e32833365f4","volume":"23","author":"G Martin-Blondel","year":"2009","unstructured":"Martin-Blondel G, Cuzin L, Delobel P, Cuvinciuc V, Dumas H, Alvarez M, Massip P, Marchou B (2009) Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management? AIDS 23:2545\u20132546. doi: 10.1097\/QAD.0b013e32833365f4","journal-title":"AIDS"},{"key":"1391_CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-011-0900-5","volume":"123","author":"I Metz","year":"2012","unstructured":"Metz I, Radue EW, Oterino A, K\u00fcmpfel T, Wiendl H, Schippling S, Kuhle J, Sahraian MA, Gray F, Jakl V, H\u00e4usler D, Br\u00fcck W (2012) Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 123:235\u2013245. doi: 10.1007\/s00401-011-0900-5","journal-title":"Acta Neuropathol"},{"key":"1391_CR4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.0305-1846.2003.00507.x","volume":"29","author":"C Trebst","year":"2003","unstructured":"Trebst C, Staugaitis SM, Tucky B, Wei T, Suzuki K, Aldape KD, Pardo CA, Troncoso J, Lassmann H, Ransohoff RM (2003) Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol Appl Neurobiol 29:584\u2013595","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-015-1391-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1391-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:24:24Z","timestamp":1559049864000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-015-1391-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,22]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1391"],"URL":"https:\/\/doi.org\/10.1007\/s00401-015-1391-6","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,22]]}}}